R-Biopharm AG
Medlab ME 2024 - Dubai
Company Description
Working in the fields of clinical diagnostics, food and feed analysis and nutrition care, R-Biopharm employs its innovative and reliable products to develop pioneering solutions for successful worldwide distribution. In the clinical field, R-Biopharm offers IVD test systems for the identification of antigens and antibodies of infectious diseases, as well as test systems for allergy diagnostics, gastroenterology, molecular diagnostics and TDM using methods like ELISAs, Rapid Tests, Blots and PCR. With the acquisition of AusDiagnostics, the Australian laboratory equipment manufacturer and multiplex specialist, R-Biopharm is expanding its existing molecular diagnostics portfolio with offering a comprehensive product range in the field of syndromic diagnostics. AusDiagnostics specialises in highly multiplexed PCR, making tests for numerous target genes with a single product easy and efficient. The patented MT-PCR method enables diagnostic decisions in human health, animal diagnostics, applied testing. With one of the industry's most comprehensive testing panel suites, the products address respiratory, enteric, STI, antimicrobial resistance, dermatophytes and more.
R-Biopharm AG
- Z6.G49
- Adem Nasraddin
- Andreas Simons
- Anke Laux
- Humberto Giassetti
- Oliver Enkelking